Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 464

    1.

    Direct renin inhibition and the kidney.

    Hollenberg NK.

    Nat Rev Nephrol. 2009 Nov 24. [Epub ahead of print]PMID: 19935744 [PubMed - as supplied by publisher]Related articles

    2.

    Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuria.

    Weir MR, Hollenberg NK, Zappe DH, Meng X, Parving HH, Viberti G, Remuzzi G.

    J Hypertens. 2009 Oct 3. [Epub ahead of print]PMID: 19809363 [PubMed - as supplied by publisher]Related articles

    3.

    A comparison of prediction equations for estimating glomerular filtration rate in pregnancy.

    Ahmed SB, Bentley-Lewis R, Hollenberg NK, Graves SW, Seely EW.

    Hypertens Pregnancy. 2009;28(3):243-55.PMID: 19440935 [PubMed - in process]Related articles

    4.

    [Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication]

    Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK.

    Ugeskr Laeger. 2009 Mar 9;171(11):881-4. Danish. PMID: 19291865 [PubMed]Related articles

    5.

    Cocoa and cardiovascular health.

    Corti R, Flammer AJ, Hollenberg NK, Lüscher TF.

    Circulation. 2009 Mar 17;119(10):1433-41. Review.PMID: 19289648 [PubMed - indexed for MEDLINE]Related articles

    6.

    Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans.

    Sarna MA, Hollenberg NK, Seely EW, Ahmed SB.

    J Hum Hypertens. 2009 Jun;23(6):407-14. Epub 2009 Jan 22.PMID: 19158821 [PubMed - indexed for MEDLINE]Related articles

    7.

    Aliskiren accumulates in Renin secretory granules and binds plasma prorenin.

    Krop M, Garrelds IM, de Bruin RJ, van Gool JM, Fisher ND, Hollenberg NK, Jan Danser AH.

    Hypertension. 2008 Dec;52(6):1076-83. Epub 2008 Nov 3.PMID: 18981317 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans.

    Sorond FA, Lipsitz LA, Hollenberg NK, Fisher ND.

    Neuropsychiatr Dis Treat. 2008 Apr;4(2):433-40.PMID: 18728792 [PubMed - in process]Related articlesFree article

    9.

    Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose?

    Hollenberg NK.

    J Hypertens. 2008 Aug;26(8):1527-32. Review. No abstract available. PMID: 18622224 [PubMed - indexed for MEDLINE]Related articles

    10.

    Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.

    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.

    Circulation. 2008 Jun 24;117(25):3199-205. Epub 2008 Jun 16.PMID: 18559696 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Aliskiren combined with losartan in type 2 diabetes and nephropathy.

    Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators.

    N Engl J Med. 2008 Jun 5;358(23):2433-46.PMID: 18525041 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Is it the dark in dark chocolate?

    Hollenberg NK, Fisher ND.

    Circulation. 2007 Nov 20;116(21):2360-2. No abstract available. PMID: 18025400 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Mortality in type 2 diabetes mellitus.

    Hollenberg NK.

    J Hypertens. 2007 Dec;25(12):2381-2. No abstract available. PMID: 17984657 [PubMed - indexed for MEDLINE]Related articles

    14.

    Renin inhibition: what are the clinical perspectives?

    Hollenberg NK.

    Semin Nephrol. 2007 Sep;27(5):511-8. Review.PMID: 17868787 [PubMed - indexed for MEDLINE]Related articles

    15.

    Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

    Hollenberg NK, Parving HH, Viberti G, Remuzzi G, Ritter S, Zelenkofske S, Kandra A, Daley WL, Rocha R.

    J Hypertens. 2007 Sep;25(9):1921-6.PMID: 17762658 [PubMed - indexed for MEDLINE]Related articles

    16.

    Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?

    Hollenberg NK, Epstein M.

    Clin J Am Soc Nephrol. 2006 Sep;1(5):1046-8. Epub 2006 Jul 19. Review. No abstract available. PMID: 17699325 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.

    Stevanovic RD, Fisher ND, Lansang CM, Freeman KD, Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2007 Jun;8(2):85-92.PMID: 17703435 [PubMed - indexed for MEDLINE]Related articles

    18.

    A brief response to Sealey and Laragh.

    Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2007 Jun;8(2):53. No abstract available. PMID: 17703429 [PubMed - indexed for MEDLINE]Related articles

    19.

    Gender and the renal nitric oxide synthase system in healthy humans.

    Ahmed SB, Fisher ND, Hollenberg NK.

    Clin J Am Soc Nephrol. 2007 Sep;2(5):926-31. Epub 2007 Aug 8.PMID: 17702739 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?

    Hollenberg NK.

    Rev Cardiovasc Med. 2007;8 Suppl 2:S7-13. Review.PMID: 17401314 [PubMed - indexed for MEDLINE]Related articles

    21.

    Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama.

    Bayard V, Chamorro F, Motta J, Hollenberg NK.

    Int J Med Sci. 2007 Jan 27;4(1):53-8.PMID: 17299579 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects.

    Perlstein TS, Gerhard-Herman M, Hollenberg NK, Williams GH, Thomas A.

    J Am Soc Nephrol. 2007 Mar;18(3):944-51. Epub 2007 Feb 7.PMID: 17287426 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Obesity and the kidney: why is the kidney at risk?

    Hollenberg NK.

    Kidney Int. 2007 Feb;71(3):187-8.PMID: 17252026 [PubMed - indexed for MEDLINE]Related articles

    24.

    Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases.

    Hollenberg NK.

    J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):63-73. Review.PMID: 17170607 [PubMed - indexed for MEDLINE]Related articles

    25.

    Effects of the PPAR-gamma agonist rosiglitazone on renal haemodynamics and the renin-angiotensin system in diabetes.

    Lansang MC, Coletti C, Ahmed S, Gordon MS, Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2006 Sep;7(3):175-80.PMID: 17094055 [PubMed - indexed for MEDLINE]Related articles

    26.

    Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.

    Stankovic AR, Fisher ND, Hollenberg NK.

    J Am Soc Nephrol. 2006 Dec;17(12):3293-9. Epub 2006 Nov 8.PMID: 17093063 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Response to Compliance With Hypertension Therapy: Why Standards Are Needed.

    Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK.

    Hypertension. 2006 Aug 21. [Epub ahead of print] No abstract available. PMID: 16923998 [PubMed - as supplied by publisher]Related articles

    28.

    Aging and vascular responses to flavanol-rich cocoa.

    Fisher ND, Hollenberg NK.

    J Hypertens. 2006 Aug;24(8):1575-80.PMID: 16877960 [PubMed - indexed for MEDLINE]Related articles

    29.

    Cocoa flavanols and brain perfusion.

    Fisher ND, Sorond FA, Hollenberg NK.

    J Cardiovasc Pharmacol. 2006;47 Suppl 2:S210-4.PMID: 16794460 [PubMed - indexed for MEDLINE]Related articles

    30.

    Hypertension, the Kuna, and the epidemiology of flavanols.

    McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, Coletti C, Campos H, Hollenberg NK.

    J Cardiovasc Pharmacol. 2006;47 Suppl 2:S103-9; discussion 119-21.PMID: 16794446 [PubMed - indexed for MEDLINE]Related articles

    31.

    The influence of dietary sodium on blood pressure.

    Hollenberg NK.

    J Am Coll Nutr. 2006 Jun;25(3 Suppl):240S-246S. Review.PMID: 16772635 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Nonmodulation and essential hypertension.

    Hollenberg NK, Williams GH.

    Curr Hypertens Rep. 2006 May;8(2):127-31. Review.PMID: 16672145 [PubMed - indexed for MEDLINE]Related articles

    33.

    Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data.

    Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK.

    Hypertension. 2006 Jun;47(6):1039-48. Epub 2006 May 1. Review. No abstract available. PMID: 16651464 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Diabetes, nephropathy, and the renin system.

    Hollenberg NK.

    J Hypertens Suppl. 2006 Mar;24(1):S81-7. Review.PMID: 16601578 [PubMed - indexed for MEDLINE]Related articles

    35.

    Renin inhibition with aliskiren: where are we now, and where are we going?

    Azizi M, Webb R, Nussberger J, Hollenberg NK.

    J Hypertens. 2006 Feb;24(2):243-56. Review.PMID: 16508564 [PubMed - indexed for MEDLINE]Related articles

    36.

    Omission of drug dose information.

    Hollenberg NK.

    Arch Intern Med. 2006 Feb 13;166(3):368; author reply 368-9. No abstract available. PMID: 16476880 [PubMed - indexed for MEDLINE]Related articles

    37.

    Renin report: spotlight on Renin: therapeutic opportunities for Renin inhibitors.

    Hollenberg NK; Members of the Renin Academy.

    J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):107-9. No abstract available. PMID: 16470491 [PubMed - indexed for MEDLINE]Related articles

    38.

    Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.

    Stevanovic RD, Price DA, Lansang MC, Fisher ND, Laffel LM, Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):78-83.PMID: 16470486 [PubMed - indexed for MEDLINE]Related articles

    39.

    (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans.

    Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M.

    Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1024-9. Epub 2006 Jan 17.PMID: 16418281 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    The role of beta-blockers as a cornerstone of cardiovascular therapy.

    Hollenberg NK.

    Am J Hypertens. 2005 Dec;18(12 Pt 2):165S-168S.PMID: 16373194 [PubMed - indexed for MEDLINE]Related articles

    41.

    The road ahead with beta-blockers: expanding treatment options in cardiovascular disease.

    Hollenberg NK.

    Am J Hypertens. 2005 Dec;18(12 Pt 2):163S-164S. No abstract available. PMID: 16373193 [PubMed - indexed for MEDLINE]Related articles

    42.

    Stress and blood pressure in Kuna Amerinds.

    Hollenberg NK, Mohres E, Meinking T, Preston M, Crespo B, Rivera A, Jackson L, Martinez G, Loken WM.

    J Clin Hypertens (Greenwich). 2005 Dec;7(12):714-20.PMID: 16330893 [PubMed - indexed for MEDLINE]Related articles

    43.

    Is there a pharmacologic basis for combination renin axis blockade?

    Hollenberg NK.

    Kidney Int. 2005 Dec;68(6):2901-3. No abstract available. PMID: 16316368 [PubMed - indexed for MEDLINE]Related articles

    44.

    Body mass index and angiotensin-dependent control of the renal circulation in healthy humans.

    Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK.

    Hypertension. 2005 Dec;46(6):1316-20. Epub 2005 Nov 14.PMID: 16286575 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

    Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.

    Diabetes Care. 2005 Aug;28(8):1988-94.PMID: 16043743 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Flavanols for cardiovascular health: the science behind the sweetness.

    Fisher ND, Hollenberg NK.

    J Hypertens. 2005 Aug;23(8):1453-9. Review.PMID: 16003167 [PubMed - indexed for MEDLINE]Related articles

    47.

    Renin inhibition: what are the therapeutic opportunities?

    Fisher ND, Hollenberg NK.

    J Am Soc Nephrol. 2005 Mar;16(3):592-9. Epub 2005 Feb 9. Review.PMID: 15703270 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    ACE and non-ACE pathways in the renal vascular response to RAS interruption in type 1 diabetes mellitus.

    Lansang MC, Stevanovic R, Price DA, Laffel LM, Hollenberg NK.

    Kidney Int. 2005 Mar;67(3):1033-7.PMID: 15698442 [PubMed - indexed for MEDLINE]Related articles

    49.

    Advanced glycation end-product cross-link breakers. A novel therapeutic pathway for cardiovascular disease.

    Hollenberg NK.

    Am J Hypertens. 2004 Dec;17(12 Pt 2):21S-22S. No abstract available. PMID: 15607431 [PubMed - indexed for MEDLINE]Related articles

    50.

    Lead exposure and chronic renal failure.

    Hollenberg NK.

    Arch Intern Med. 2004 Dec 13-27;164(22):2507; author reply 2508-9. No abstract available. PMID: 15596656 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...